To delineate with computed tomography (CT) the anatomic regions containing the supraclavicular (SCV) and infraclavicular (IFV) nodal groups, to define the course of the brachial plexus, to estimate the actual radiation dose received by these regions in a series of patients treated in the traditional manner, and to compare these doses to those received with an optimized dosimetric technique.
Definition of the Supraclavicular and Infraclavicular Nodes:
Implications for Three-dimensional CT-based Conformal Radiation Therapy 1 PURPOSE: To delineate with computed tomography (CT) the anatomic regions containing the supraclavicular (SCV) and infraclavicular (IFV) nodal groups, to define the course of the brachial plexus, to estimate the actual radiation dose received by these regions in a series of patients treated in the traditional manner, and to compare these doses to those received with an optimized dosimetric technique.
MATERIALS AND METHODS:
Twenty patients underwent contrast material-enhanced CT for the purpose of radiation therapy planning. CT scans were used to study the location of the SCV and IFV nodal regions by using outlining of readily identifiable anatomic structures that define the nodal groups. The brachial plexus was also outlined by using similar methods. Radiation therapy doses to the SCV and IFV were then estimated by using traditional dose calculations and optimized planning. A repeated measures analysis of covariance was used to compare the SCV and IFV depths and to compare the doses achieved with the traditional and optimized methods.
RESULTS:
Coverage by the 90% isodose surface was significantly decreased with traditional planning versus conformal planning as the depth to the SCV nodes increased (P Ͻ .001). Significantly decreased coverage by using the 90% isodose surface was demonstrated for traditional planning versus conformal planning with increasing IFV depth (P ϭ .015). A linear correlation was found between brachial plexus depth and SCV depth up to 7 cm.
CONCLUSION:
Conformal optimized planning provided improved dosimetric coverage compared with standard techniques.
Increasing emphasis is being placed on the importance of regional therapy in the management of early-stage breast cancer. Recent randomized trials have shown a significant benefit in survival by the addition of postmastectomy radiation therapy in patients with positive axillary nodes (1) (2) (3) . Comprehensive radiation therapy fields used in these trials have included not only the chest wall but also the supraclavicular (SCV), infraclavicular (IFV) (axillary apex), internal mammary, and axillary lymph nodes. Although the exact contribution of regional treatment to the survival benefit is uncertain, it is clear from these studies that treatment to regional sites is of therapeutic benefit.
Management of the axilla in the treatment of breast cancer is primarily surgical, with axillary recurrence in approximately 1%-2% of patients following a standard level I, II dissection (4 -6) . However, as the number of involved axillary nodes identified in a level I, II dissection increases, the risk of involvement of level III, also known as the apex of the Radiation Oncology axilla or the IFV region, and the SCV nodes increases as well (7, 8) . Radiation therapy has traditionally been used to treat patients at high risk for microscopic residual disease of the SCV and IFV regions, resulting in rates of regional failure as first failure of only 0.0%-1.5% (4, 5) .
Historically, the SCV nodes and the axillary apex have been treated with radiation therapy by using a single anterior field, as shown in Figure 1 , with full dose prescribed to a point in the SCV fossa 3 cm deep to the surface of the skin. This field has generally extended superiorly to the thyrocricoid membrane, inferiorly to the inferior aspect of the clavicular head, medially to the lateral aspect of the sternocleidomastoid muscle, and laterally to the humeral head. Although the nodes in these regions considered at risk for microscopic disease are present within these field borders, tissues not at risk, including shoulder musculature, are also included, which increases the potential for radiation-associated complications (9) . Uniform dosing to a depth of 3 cm in all patients for an arbitrarily defined nodal volume is also of concern, given the range in body habitus, weights, and depth of subcutaneous adipose tissue among individuals.
Therefore, it is desirable to define the nodal regions at risk for spread of breast cancer such that full-dose radiation therapy could be delivered conformally to these target volumes. It is also important to estimate the dose actually received by radiation-sensitive structures, such as the brachial plexus, by using traditional dosimetry techniques and to compare these values with the doses received by using radiation therapy optimized to treat target nodal volumes. Thus, the goals of this study were to delineate on computed tomographic (CT) scans the anatomic regions containing the SCV and ICV nodal groups, to define the course of the brachial plexus, to estimate the actual radiation dose received by these regions in a series of patients treated in the traditional manner, and to compare these doses with those received by using an optimized dosimetric technique.
MATERIALS AND METHODS
Contrast material-enhanced CT scans obtained in 20 patients consecutively treated with radiation therapy at the University of Michigan School of Medicine, Ann Arbor, were used to study the anatomy of the SCV fossa and axillary apex. Each patient had been diagnosed with stage II breast cancer with positive axillary nodes and had undergone a modified radical mastectomy with a level I, II nodal dissection. Three patients had bilateral disease; thus, 23 SCV regions were available for evaluation. Of the 23 eligible regions, two could not be used due to poor opacification of the blood vessels in the SCV fossa. Following completion of chemotherapy, customized cradles (Alpha; KGF, Chesterfield, Mich) (1) for each patient were fabricated for immobilization during radiation therapy planning and treatment with the patient's ipsilateral (or bilateral) arm or arms above the head.
CT was then performed for three-dimensional treatment planning of the chest wall, supraclavicular fossa, and superior internal mammary nodes per routine protocol for treatment of node-positive disease. Scanning was performed with a variety of third-generation CT scanners with a field of view selected to include the entire patient. Patient CT sections were contiguously obtained at 3-or 5-mm intervals from the mid-neck to the diaphragm during bolus administration of nonionic intravenous contrast material. For this study, the CT images included an area that extended from the neck to the inferior aspect of the clavicular head. With the aid of a senior radiologist (D.J.Q.), the following structures were carefully outlined on each CT section by using the three-dimensional system: the anterior scalene muscle, the brachial plexus, the carotid sheath, the sternocleidomastoid muscle, the pectoralis major and minor muscles, and the subclavian artery.
Anatomically, the SCV fossa is subdivided into two compartments: the lesser SCV fossa, which is the depression between the two heads of the sternocleidomastoid muscle, and the greater SCV fossa, which is at the base of the posterior triangle of the neck and is also referred to as the omoclavicular triangle (10) . The entire SCV fossa, defined as the composite of these two compartments, was then outlined on each CT section by using reproducible anatomic boundaries. Medially, the SCV fossa was considered to extend to the lateral edge of the trachea, excluding the thyroid gland and thyroid cartilage superiorly. Anteriorly, the SCV fossa was bounded by the deep surface of the sternocleidomastoid muscle and the deep cervical fascia. The posterolateral border of the fossa was considered to be at the anterior and medial borders of the anterior scalene muscle, while the posteromedial border extended medially to the carotid artery and internal jugular vein. At the inferior aspect of the SCV fossa, the posterior border was defined by the subclavian artery.
The IFV fossa was also outlined on successive CT sections by using easily delineated anatomic structures. The superior border was defined as the most superior aspect of the pectoralis minor muscle. The inferior border was defined at the level of the insertion of the clavicle into the manubrium. The IFV fossa extended laterally to the medial border of the pectoralis minor muscle and medially to the lateral edge of the clavicle. The anterior extent of the fossa was considered to be the deep surface of the pectoralis major muscle and the posterior extent was defined by the subclavian-axillary artery.
The course of the brachial plexus was also outlined on each CT section. The brachial plexus usually arises from the roots of the fifth cervical (C5) through the first thoracic (T1) nerves. At approximately the T1 vertebral level, the brachial plexus courses between the anterior and middle scalene muscles. In the inferior portion of the supraclavicular fossa, the brachial plexus closely follows the path of the subclavian artery. Specifically, the neural bundles are located just anterior to the subclavian artery, and then course immediately posterior and parallel to the subclavian artery. The terminal branches of the plexus then surround the subclavian-axillary artery. Thus, even though the brachial plexus can be difficult to identify on transverse CT images, the anterior and middle scalene muscles and subclavian-axillary arteries can be used to identify the expected course of the plexus (11) .
Bilateral neck dissections were carried out on two cadavers to confirm the location of the SCV lymph node chains. Specifically, by using blunt dissection, a vertical incision was made along the anterior midline extending from just below the mandible to the inferior aspect of the manubrium. Another incision was made from the most lateral aspect of the neck just beneath the angle of the mandible toward the acromion. Both cuts were then connected superiorly by a horizontal incision running just below the mandible. The skin, subcutaneous tissue, and the platysma muscle were reflected down to the level of the manubrium. The deep cervical fascia investing the sternocleidomastoid muscle was removed, and the sternocleidomastoid muscle was severed from its nuchal attachment to expose the SCV fossa. The omohyoid muscle was also detached from its hyoid attachment and reflected laterally. By using a saw, the middle one-third of the clavicle was removed, and the pectoralis major muscle attached to that portion of the clavicle was reflected toward the chest wall to gain easy access to the SCV fossa. The fossa was essentially a space filled with adipose tissue containing several lymph nodes embedded at various depths. The internal jugular and carotid vessels were noted as the medial extent of this fossa. The fatty tissue in the SCV fossa was lifted and revealed the scalene muscles and the subclavian artery on the floor of the fossa.
Radiation therapy doses to the SCV and IFV regions were estimated by using both a traditional and a conformal optimized technique. For the traditional method, a single anterior treatment field was set at 97 cm source-to-skin distance by using an asymmetric inferior field border such that the lower jaw was placed at the central axis, at the base of the head of the clavicle. The gantry was angled 10°a way from the spinal cord, and a focused block was placed to maintain an off-cord approach. The dose to the SCV field was calculated to a point located 1.0 -1.5 cm superior to the clavicular head approximately 3 cm lateral to the block edge, at a depth of 3 cm. Doses received at the 90% isodose surface for the SCV and IFV volumes were then calculated by using the UM Plan planning system (12) .
For the conformal optimized plans, the gantry angle was modified in 13 of 21 cases (15°angle, six patients; 20°angle, six patients; and 25°angle, one patient) to cover the target SCV and IFV volumes. The depth of normalization was determined such that the 90% isodose surface covered the optimized SCV and IFV volumes. Six-megavolt photons and lung inhomogeneity corrections were used for both calculation techniques. The depth to the deepest aspect of the target volume was measured with the gantry angle set at 10°in all patients.
A repeated measures analysis of covariance was used to compare the IFV and SCV depths and doses between the traditional and optimized methods. This method is analogous to a paired-comparison t test in that it is used to explicitly estimate the within-patient correlation between plans. These models were fit by using software (PROCMIXED in SAS LINUX, version 8.2; SAS Institute, Cary, NC).
The minimum (min) and maximum (max) depths from the skin to the brachial plexus nerves were measured on each scan. The mean brachial plexus (BP) depth, calculated as (BP min ϩ BP max)/2, was then correlated to the depth of the SCV volume. Figure 2a shows the left SCV fossa from a cadaver, with the sternocleidomastoid muscle transected to expose underlying structures. It is accompanied by a diagram illustrating the pertinent anatomical structures (Fig 2b) . Figure 3 shows the corresponding structures on successive transverse CT scans from one patient treated with postmastectomy radiation therapy. The SCV fossa is medial at the superior aspect of this region (Fig 3, a-e ) and then extends laterally as the nodal regions approach the clavicle (Fig 3, f-j) . The superior aspect of the IFV region is noted in Figure 3 , e, located at the superior and medial extent of the pectoralis minor muscle. The medial extent of this region approaches midline inferiorly as it follows the course of the clavicle (Fig 3, k) . Figure 4 shows a composite view of the SCV and IFV volumes superimposed on a standard anterior SCV radiation therapy field. As compared with the SCV field shown in Figure 1 , restricting radiation therapy dose to defined nodal volumes at risk spares tissues at the lateral and superior aspects of a standard SCV field.
RESULTS
Of the 21 scanned regions suitable for study, the median maximum depth of the SCV nodes was 5.0 cm (range, 3.9 -8.3 cm). In the optimized conformal plans, 100% of the SCV volume was covered by the 90% isodose surface. This compares with a median of 93.3% of the SCV volume (range, 98.2%-44.7%) covered by the 90% isodose surface in the traditional plans. As shown in Figure 5 , however, as the depth to the SVC nodes increases, the percentage of the SCV volume encompassed within the 90% isodose surface significantly decreases for cases of therapy planned by using traditional planning versus the conformal optimized plan (P Ͻ .001).
The maximum median depth of the IFV nodes as measured in the 20 CT scans Figure 3 . Transverse CT sections at 3-mm intervals (window width, 500 HU; window level, 50 HU) with outlines of the SCV and IFV fossae and the course of the brachial plexus, with the muscles and vessels that radiographically define these volumes and nerves. CT section in a is at the level of the thyrocricoid membrane, which clinically corresponds to the superior level of the SCV fossa. Successive 3-5-mm interval sections are presented to the inferior level of the IFV fossa, which corresponds clinically to the base of the clavicular head (Fig 3 continues) . was 5.6 cm (range, 3.3-7.3 cm). One hundred percent of the IFV volume was encompassed by the 90% isodose surface in the optimized plan; this compares with a median of 87.7% (range, 100.0%-47.8%) of the IFV volume covered by the 90% isodose surface in the traditional plan. Figure 6 shows the comparison of the IFV depth with percentage of the IFV volume within the 90% isodose surface and demonstrates a significant difference between the regression lines for the conformal optimized and traditional plans (P ϭ .015), which suggests that a decreased radiation dose would be delivered to nodes at a depth of 4 cm and greater.
Because the proximal and distal course of the brachial plexus nerves and the patient body habitus varied, the distance from the skin to the plexus varied according to position of the nerves and according to each patient. The median minimum depth to the plexus, per measurements from CT scans, was 2.3 cm (range, 0.5-4.0 cm) and median maximum depth to the plexus was 6.5 cm (range, 3.8 -9.1 cm). The SCV depth was correlated (r ϭ 0.77, P Ͻ .01) with the mean brachial plexus, represented by BP, depth calculated with (BP min ϩ BP max)/2, as shown in Figure 7 . The relationship appeared to be linear when SCV depth was less than 7 cm; there were not enough subjects with mean SCV depth greater than 7 cm to determine with certainty if the mean brachial plexus depth stopped increasing when the SCV depth exceeded 7 cm. The doses to the brachial plexus volume for the techniques of the two plans were then compared by using the calculated dose distributions. Eightyone percent (range, 49.0%-95.4%) of the brachial plexus was encompassed within Figure 3 (continued). Transverse CT sections at 3-mm intervals (window width, 500 HU; window level, 50 HU) with outlines of the SCV and IFV fossae and the course of the brachial plexus, with the muscles and vessels that radiographically define these volumes and nerves. CT section in a is at the level of the thyrocricoid membrane, which clinically corresponds to the superior level of the SCV fossa. Successive 3-5-mm interval sections are presented to the inferior level of the IFV fossa, which corresponds clinically to the base of the clavicular head.
the 90% isodose surface in the optimized plans versus 42.2% (range, 2.4%-78.8%) in the traditional plans.
DISCUSSION
By using information obtained from cadaver dissection and CT-based imaging, we have identified anatomic structures that localize the regions containing the SCV and IFV lymph nodes. We have also shown the range in depths of these nodes in a cohort of patients. In identifying these structures, we have superimposed the dose calculations traditionally delivered to these regions and have estimated the doses actually received by these nodal groups. We have shown that for both the SCV and IFV nodes, prescription of dose to a uniform depth of 3 cm significantly underdoses these regions as the nodal depths exceed 3 cm when compared with a conformal optimized technique. Thus, body habitus and patient separation (thickness) can significantly alter dose delivered to these nodal groups unless the actual location of these nodes can be identified and the plans can be optimized appropriately.
As shown in the comparison of Figures  1 and 4 , more precise definition of these nodal regions can minimize unnecessary treatment to uninvolved tissues. Regional radiation therapy can significantly increase shoulder movement dysfunction as shown in the functional analysis of shoulder motion following the Danish trials in which women were randomly assigned to receive postmastectomy radiation therapy (9) . Thus, delivery of radiation therapy to only those tissues that require treatment could potentially result in decreased rates of radiation therapyrelated shoulder morbidity. It is also possible that the occurrences of arm edema could be decreased by using radiation therapy fields tailored to specific individualized anatomic regions. The lateral extent of the supraclavicular field has been implicated in the risk of radiation-associated lymphedema, with extension of the lateral border of the SCV field associated with increasing risk of arm edema (13) . As shown in Figure 4 , additional sparing of lateral tissues is possible with careful delineation of the SCV and IFV fossae. As both limited arm mobility and lymphedema can result in permanent arm dysfunction in breast cancer survivors, measures should be taken which could improve long-term functional outcome.
The pathway of the brachial plexus through the SCV region has been defined by using structures that are readily identifiable on CT scans, such as the anterior and middle scalene muscles and the subclavian artery. We have shown the variation in the depth of the brachial plexus from its proximal to its distal extent between patients. Estimations of dose received to the brachial plexus for traditional versus optimized planning revealed that higher doses are received to the plexus by using the optimized plans. Although not well documented, clinical studies of peripheral nerve tolerance suggest a 5% occurrence of radiation-induced brachial plexus injury at doses of 60 Gy in 2-Gy fractions (14) . This dose threshold is consistent with the 0%-1% rate of brachial plexopathy observed in patients treated with breast and regional irradiation for breast-conserving therapy, where doses of 46 -50 Gy have been delivered to a traditional SCV field to a depth of 3 cm (15, 16) . Thus, despite the delivery of a higher dose of radiation to the brachial plexus volume by using the conformal optimized technique, a higher rate of complications would not be expected with the dose restricted to 50 Gy. Knowledge of the course of the brachial plexus with respect to the SCV nodes should be helpful, however, in estimating the risk of radiation-induced brachial plexus injury in patients with bulky SCV nodes requiring high-dose radiation therapy.
In recent years, there has been substantial interest and work throughout the radiation oncology community involving the development of conformal therapy (17, 18) . Conformal radiation therapy refers to the delivery of radiation which conforms in three dimensions to the shape of the defined target or targets while at the same time minimizes dose to normal tissue. Various optimization algorithms or inverse planning techniques have been clinically applied to improve dose conformation. The most promising optimization technique currently in use is called intensity-modulated radiation therapy (IMRT) in which the usual reliance on uniform-intensity radiation fields is replaced by a variable-intensity pattern that is determined with the aid of a computerized optimization algorithm (19) . The combination of IMRT delivery with inverse planning optimization is expected to achieve better dosimetric results than normal plans. It is hopeful that IMRT will result in either the improvement of local disease control due to improved coverage of the target or reduced normal tissue dose while achieving the same tumor coverage. To achieve these goals, a defined clinical target must be determined that allows not only restriction of the treatment field to the designated targets but also allows three-dimensional delivery of therapy. In the case of breast cancer treatment, the simple traditional paradigm of treatment delivery in which separate fields are used to treat the breast or chest wall and the SCV or IFV regions could be replaced by a three-dimensional treatment approach to a more carefully defined target volume that includes the breast or chest wall and specific nodal volumes. Thus, the tissues in the thorax and neck or shoulder region that do not require treatment could be spared. While this is currently an area of intense research, defining nodal volumes, as done here, is the first step to achieving dose delivery optimization.
There may be limitations in the interpretation of these results. In patients at risk for microscopic nodal disease, the SCV nodes cannot be visualized on CT scans. Thus, surrogate structures are used to identify the tissue volumes containing the nodes. For that reason, after thoroughly reviewing the regional anatomy in anatomic textbooks, we dissected the neck regions bilaterally in two cadavers and confirmed the location of these nodes, as shown in Figure 2a . This series contains a limited number of patients, which limits the power of these observations. Despite the small number of patients, however, this series contains a spectrum of body habitus which allowed us to demonstrate significant dose differences between traditional and optimized radiation therapy plans with respect to tissue depth. Therefore, our quantitative results should be applicable to larger data sets.
In summary, the three-dimensional tissue volumes containing the SCV and IFV lymph nodes were defined on CT scans by using readily identifiable anatomic landmarks. Optimized radiation therapy planning provided improved coverage of these target structures compared with traditional planning, with greater sparing of uninvolved tissues. The development of this systematic approach in defining the structures at risk and conforming therapy to these target structures is a necessary step toward the next level of dose optimization in the use of radiation therapy for carcinoma of the breast. Line graph shows correlation of the mean brachial plexus depth, defined as the average of the minimum and maximum depths to the brachial plexus, and the depth of the SCV nodes from the 21 scanned regions.
